.
Angewandte
Communications
DOI: 10.1002/anie.201301694
Frustrated Lewis Pairs
Regioselective Metalations of Pyrimidines and Pyrazines by Using
Frustrated Lewis Pairs of BF3·OEt2 and Hindered Magnesium– and
Zinc–Amide Bases**
Klaus Groll, Sophia M. Manolikakes, Xavier Mollat du Jourdin, Milica Jaric, Aleksei Bredihhin,
Konstantin Karaghiosoff, Thomas Carell, and Paul Knochel*
The functionalization of diazines is of great importance,
because these N-heterocycles are present in numerous natural
products, pharmaceuticals, and agrochemicals.[1] They also
find applications in materials science and polymer chemis-
try.[2] The directed metalation and further functionalization of
these electron-deficient N-heterocycles can be realized with
ate bases[3] and in some cases with lithium bases.[4] However,
low temperature and carefully designed reaction conditions
are required owing to the low stability of the resulting
Scheme 1. Switchable, regioselective metalation of the pyrimidine 1a.
À
lithitated N-heterocycles. Recently, the C H activation of
various N-heteroaromatics has also been reported.[5] More-
over, a range of LiCl-solubilized TMP–metal bases (TMP =
2,2,6,6-tetramethylpiperidyl) are known.[6] They display
a high kinetic basicity and give access to several metalated
diazines[7] and purines.[8] It was also found that these metallic
amide bases are compatible with a strong Lewis acid, such as
BF3·OEt2.[9] Thus, the reactivity of the sterically hindered
TMP base is not annihilated by BF3·OEt2, but on the contrary,
a synergetic effect is observed (dual activation). This effect
allows a regioselective metalation of various substituted
pyridines and derivatives,[10] which is not possible without
the use of this Lewis pair combination. This compatibility of
a strong Lewis acid with a Lewis base as a result of steric
hindrance corresponds directly to the concept of frustrated
Lewis pairs.[11] Herein, we report a new BF3-assisted regiose-
lective metalation of biologically relevant pyrimidine deriv-
atives and purines. As an application, we developed a new
strategy for the BF3-mediated regioselective full functional-
ization of pyrazines.
expected iodide 3a is isolated in 85% yield. In contrast, the
reaction of the pyrimidine 1a with BF3·OEt2 (1.1 equiv, 08C,
15 min) then TMPZnCl·LiCl (4, 1.5 equiv, THF, À208C, 1 h)
leads to a quantitative metalation at position 2. After
a copper-mediated allylation with 3-bromocyclohexene (5a),
the desired 2-functionalized pyrimidine 3b was isolated in
92% yield (Scheme 1). This behavior might be explained by
an increased acidity at position 2 owing to the complexation
of BF3 with the pyrimidine ring rather than with the sterically
hindered Lewis base TMPZnCl·LiCl, allowing a complete
switch of regioselectivity.[12]
The zincated intermediate derived from 1a undergoes
a smooth Negishi cross-coupling[13] with 4-iodoanisole (5b)
using 2% [Pd(dba)2] (dba = dibenzylideneacetone) and 4%
tfp (tfp = tri-(2-furyl)phosphine),[14] affording the 2-arylated
pyrimidine 3c in 89% yield (Table 1, entry 1). This regiose-
lective metalation is quite general, the pyrimidines 1b–d are
also selectively zincated in position 2 regardless of their
substitution pattern. After allylation, iodolysis, or cross-
coupling, the expected 2-functionalized pyrimidines 3d–i are
obtained in 66–71% yield (entries 2–7).
More complex pyrimidine derivatives, such as the thieno-
pyrimidines[15] 6a and 6b, display a similar regioselectivity
switch (Scheme 2). Thus, the treatment of 6a (R = NMe2)
with TMPZnCl·LiCl (4) leads to a smooth deprotonation of
the most acidic proton of 6a (i.e. position 6) giving, after
cross-coupling, the 6-arylated product 7a in 83% yield.
Alternatively, addition of BF3·OEt2 to 6a,b followed by
TMPZnCl·LiCl (4) leads to a regioselective zincation at
position 2 (over 10:1) of the pyrimidine ring. Palladium-
catalyzed cross-coupling or copper-mediated allylation fur-
nishes the 2-functionalized thienopyrimidines 8a and 8b in
70–77% yield (Scheme 2).
Thus, we have found that the use of BF3·OEt2 allows the
orthogonal metalation of the pyrimidine scaffold. Treating
4,6-dimethoxypyrimidine (1a) with TMPMgCl·LiCl (2,
1.1 equiv, THF, 08C, 40 min) provides a regioselective mag-
nesiation at position 5 (Scheme 1). After iodolysis, the
[*] K. Groll, S. M. Manolikakes, Dr. X. M. du Jourdin, Dr. M. Jaric,
Dr. A. Bredihhin, Prof. Dr. K. Karaghiosoff, Prof. Dr. T. Carell,
Prof. Dr. P. Knochel
Department Chemie, Ludwig-Maximilians-Universitꢀt Mꢁnchen
Butenandtstrasse 5-13, Haus F, 81377 Mꢁnchen (Germany)
E-mail: paul.knochel@cup.uni-muenchen.de
[**] We thank the Fonds der Chemischen Industrie, the SFB 749 and the
Alexander von Humboldt Foundation for financial support. We also
thank BASF SE (Ludwigshafen), W. C. Heraeus GmbH (Hanau), and
Rockwood Lithium GmbH (Frankfurt) for the generous gift of
chemicals.
As a metalation of purines at position 2 is only reported
by a lithiation-mediated stannyl transfer,[16] we have inves-
tigated the magnesiation of functionalized purine derivatives
in this position. Whereas, purine 9 is reluctant to undergo
Supporting information for this article is available on the WWW
6776
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2013, 52, 6776 –6780